Porton Biologics Funding: $62M Raised, Series A (2021)

Porton Biologics is based in Suzhou, China. It has raised $62M in total funding. Latest round: Series A. Backed by SDIC, GL Ventures, HM Capital.

Porton Biologics funding overview

Porton Biologics is based in Suzhou, China. Porton Biologics has raised $62M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2021. The round record for Porton Biologics runs through 2021; nothing later has been disclosed. Investors on record include SDIC, GL Ventures, HM Capital, Huashan Ruilian, Momentum Venture. 5 distinct backers are named across the disclosed rounds.

Porton Biologics at a glance

Total raised
$62M
Latest round
Series A
Latest round date
April 2021
Headquarters
Suzhou, China
Notable investors
SDIC, GL Ventures, HM Capital, Huashan Ruilian, Momentum Venture

Frequently asked about Porton Biologics funding

How much has Porton Biologics raised?
Porton Biologics has raised $62M in total disclosed funding across the rounds on record.
Who has invested in Porton Biologics?
SDIC, GL Ventures, HM Capital, Huashan Ruilian, Momentum Venture are named among the investors backing Porton Biologics.
What was the latest Porton Biologics funding round?
The most recent disclosed round is a Series A, announced in April 2021.
Where is Porton Biologics based?
Porton Biologics is based in Suzhou, China.
When did Porton Biologics last raise?
The last disclosed Porton Biologics round closed in April 2021 at Series A.

Every Porton Biologics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Suzhou at a similar stage.

Companies related to Porton Biologics (26)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026